20 results on '"Gartland, Margaret"'
Search Results
2. Characterization of clinical envelopes with lack of sensitivity to the HIV-1 inhibitors temsavir and ibalizumab
3. Week 240 Efficacy and Safety of Fostemsavir Plus Optimized Background Therapy in Heavily Treatment-Experienced Adults with HIV-1
4. Safety and efficacy of the HIV-1 attachment inhibitor prodrug fostemsavir in heavily treatment-experienced individuals: week 96 results of the phase 3 BRIGHTE study
5. Clinical evidence for a lack of cross-resistance between temsavir and ibalizumab or maraviroc
6. A Phenotypic High-Throughput Screen with RSV-Infected Primary Human Small Airway Epithelial Cells (SAECs)
7. Week 96 Genotypic and Phenotypic Results of the Fostemsavir Phase 3 BRIGHTE Study in Heavily Treatment-Experienced Adults Living with Multidrug-Resistant HIV-1
8. Clinical evidence for a lack of cross-resistance between temsavir and ibalizumab or maraviroc
9. GSK983: A novel compound with broad-spectrum antiviral activity
10. Prevalence of gp160 polymorphisms known to be related to decreased susceptibility to temsavir in different subtypes of HIV-1 in the Los Alamos National Laboratory HIV Sequence Database
11. Susceptibility of global HIV-1 clinical isolates to fostemsavir using the PhenoSense® Entry assay
12. Fostemsavir in Adults with Multidrug-Resistant HIV-1 Infection
13. Susceptibility of global HIV-1 clinical isolates to fostemsavir using the PhenoSense® Entry assay.
14. Safety, efficacy, and dose response of the maturation inhibitor GSK3532795 (formerly known as BMS-955176) plus tenofovir/emtricitabine once daily in treatment-naive HIV-1-infected adults: Week 24 primary analysis from a randomized Phase IIb trial
15. Potent inhibitors of HIV-1 integrase display a two-step, slow-binding inhibition mechanism which is absent in a drug-resistant T66I/M154I mutant
16. Discovery of novel P3-oxo inhibitor of hepatitis C virus NS3/4A serine protease
17. IMPACT OF BASELINE FACTORS ON VIROLOGIC RESPONSE TO bNAb VH3810109 (N6LS) IN BANNER.
18. The Naphthyridinone GSK364735 Is a Novel, Potent Human Immunodeficiency Virus Type 1 Integrase Inhibitor and Antiretroviral
19. The 5′ untranslated region of GB virus B shows functional similarity to the internal ribosome entry site of hepatitis C virus
20. An infectious molecular clone of a Japanese genotype 1b hepatitis C virus
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.